Clinical Trial Update: Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford [NA]

View source ↗

Summary

Stanford’s clinical trial seeks to evaluate long-term cognitive, neuropsychiatric, and functional outcomes in adults treated with CAR-T therapy for aggressive N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Non Hodgkin Lymphoma | NA | Status: NOT_YET_RECRUITING